<div class="table-wrapper" markdown="block">

| Story | Cancer type | Organism | Modality | Link | Antibodies targets in the story |
| :-- | :-- | :-- | :-- | :-- | :-- |
| BRCA-WT TNBC 1 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-1#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA-WT TNBC 2 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-2#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA-WT TNBC 3 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-3#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA-WT TNBC 4 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-4#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA-WT TNBC 5 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-5#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA-WT TNBC 6 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA-WT-6#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 1 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-1#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 2 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-2#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 3 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-3#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 4 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-4#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 5 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-5#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 6 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-6#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 7 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-7#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 8 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-8#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 9 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-9#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| BRCA1-associated TNBC 10 | Breast | Human | CyCIF | [Here](https://www.cycif.org/data/mehta-2020/osd-BRCA1-associated-10#s=0) | CD163, CD68, Keratin, Ki67, 53BP1, CD4, CD8a, FOXP3 |
| Clinical Benefit - Cisplatin Biopsy | Breast  | Human | CyCIF | [Here](https://www.cycif.org/data/keenan-2020/osd-cis.html#s=0) | pCDK1/2/3/5, pHH3, pan-cytokeratin, CD8a, CD4, CD68, CD163, CD14 |
| Clinical Benefit - Cis Wee1i Biopsy | Breast  | Human | CyCIF | [Here](https://www.cycif.org/data/keenan-2020/osd-Wee1.html#s=0) | pCDK1/2/3/5, pHH3, pan-cytokeratin, CD8a, CD4, CD68, CD163, CD14 |
| No Clinical Benefit - Cisplatin Biopsy | Breast  | Human | CyCIF | [Here](https://www.cycif.org/data/keenan-2020/osd-25_C1_a.html#s=0) | pCDK1/2/3/5, pHH3, pan-cytokeratin, CD8a, CD4, CD68, CD163, CD14 |
| No Clinical Benefit - Cis Wee1i Biopsy | Breast  | Human | CyCIF | [Here](https://www.cycif.org/data/keenan-2020/osd-25_C2_b.html#s=0) | pCDK1/2/3/5, pHH3, pan-cytokeratin, CD8a, CD4, CD68, CD163, CD14 |
| Spatially resolved immune profiling of lung adenocarcinoma mouse model KRas/p53 mutant | Lung  | GEMM | CyCIF | [Here](https://www.cycif.org/data/gaglia-mit-ludwig-2020/osd-gemm-lung.html#s=0) | TTF1, CD45, CD11c, CD45R, FOXP3, CD4, CD8, Granzyme B, Perforin |
| Tonsil | Normal | Human | CyCIF | [Here](https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_1#s=0) | CD45, IBA1, Keratin, α-SMA, CD20, CD3d, CD4, CD8a, CD14, CD163, CD11b, CD68 |
| Tonsil | Normal | Human | IHC | [Here](https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-TONSIL_IHC#s=0) | CD3, CD4, CD8, CD20, CD68, FOXP3, PD1, PD-L1 |
| Lung-1-LN: Lung adenocarcinoma metastasis to lymph node | Lung | Human | CyCIF | [Here](https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_1#s=0) | CD45, IBA1, Keratin, α-SMA, CD20, CD4, CD8a, CD163, CD11b, CD68, CD14,  |
| Lung-2-BR: Lung squamous cell carcinoma metastasis to brain | Lung | Human | CyCIF | [Here](https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_2#s=0) | CD45, IBA1, Keratin, α-SMA, CD20, CD4, CD8a, CD163, CD11b, CD68, CD14,  |
| Lung-3-PR: Primary lung squamous cell carcinoma | Lung | Human | CyCIF | [Here](https://www.cycif.org/data/du-lin-rashid-nat-protoc-2019/osd-LUNG_3#s=0) | Keratin, α-SMA, CD45, IBA1, PD-L1, CD3d, CD20, CD4, FOXP3, CD8a, PD1, LAG3, CD163, CD68, CD11b, CD14 |

</div>